InvestorsHub Logo
Followers 800
Posts 50852
Boards Moderated 1
Alias Born 12/12/2004

Re: None

Friday, 12/19/2014 11:23:59 AM

Friday, December 19, 2014 11:23:59 AM

Post# of 97237
TRXC up 64% @ 3.87 on FDA 510-k news:

(NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced the successful completion of four general surgery and urology procedures using its SurgiBot system patient-side robotic surgery system. Management also stated that the preparation of its FDA 510(k) filing is proceeding as planned, and affirmed prior guidance of its intention to submit the filing in mid-2015.

Using the SurgiBot system in the porcine model, Dr. Juan-Carlos Verdeja, a general surgeon and Chief of General Surgery at Baptist Health Medical Group in Miami, performed two cholecystectomy (gallbladder removal) procedures, and Dr. Michael N. Ferrandino, a urologist and Director of Minimally Invasive Urologic Surgery at the Duke Division of Urology, performed two nephrectomy (kidney removal) procedures.

"The SurgiBot system has the ability to offer multiple instruments and a camera through a single small incision. It is designed to limit surgical trauma while enabling the surgeon with advanced vision, dexterity and control," said Dr. Verdeja. "I was impressed with the system's capabilities, providing ergonomic benefits as well as excellent visualization in 3DHD. Being able to perform the procedure from within the sterile field, and with tactile feedback, increases the control a surgeon has when performing surgery."

Dr. Ferrandino commented, "I can envision the SurgiBot being utilized in a wide variety of surgical procedures. This system provides an elegant and effective combination of the best of single-port, laparoscopic and robotic approaches in surgery."

"These pre-clinical procedures support our expectation for commercial success with the SurgiBot," said Todd M. Pope, president and CEO of TransEnterix. "We are pleased with our progress and our FDA 510(k) filing remains on track for a mid-2015 submission."

DUKE BASKETBALL and NOTRE DAME FOOTBALL

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.